Sharable Knowledge Mining Platform

Liver Cancer Clinical Trial

Official title:

Sharable Knowledge Mining Platform for Clinical Data Extraction, and Medical Knowledge and Mining Services Sharing

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01178801
• Other study ID #: 201002032R
• Status: Recruiting
• Phase: N/A
• First received: May 30, 2010
• Last updated: August 9, 2010
• Start date: March 2010
• Est. completion date: March 2013

Study information

• Verified date: July 2010
• Source: National Taiwan University Hospital
• Contact: Feipei Lai
• Phone: +886-2-33665001
• Email: flai[@]ntu.edu.tw
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

As a result of increasing adoption of health information systems in hospitals, more and more health records can be gathered and accumulated in the healthcare data repository. For this reason, the opportunity of analyzing and mining the healthcare data for quality improvement is increasing and becoming more and more important.

The purpose of the project is to gather the clinical data relevant to liver cancer, and adopt the knowledge discovery and mining modules in information technology (IT) for analyzing and discovering the knowledge from the gathered clinical data.

We can analyze the gathered clinical data for comparing the outcomes of different treatment strategies, finding out new diagnosis and staging criteria and factors, and other hidden knowledge included in the clinical data.

Afterwards, the discovered results and the mining algorithms can be shared though the sharable knowledge mining platform provided by our project.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10000
• Est. completion date: March 2013
• Est. primary completion date: March 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Clinical data of patients with liver cancer. (ICD9 Code is 155.0)

• Males and females

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

• Liver Cancer
• Liver Neoplasms

Locations

Country	Name	City	State
Taiwan	National Taiwan University	Taipei

Sponsors (2)

Lead Sponsor	Collaborator
National Taiwan University Hospital	National Science Council, Taiwan

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the relationship between the clinical data and the decision of treatment strategies		2 years	No